person

Clotilda-Alexandra R.

Country
Romania
Department
Dermatology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 3 partner sites.

Specializations

Dermatology & Skin Autoimmunity

Clinical work centers on cutaneous diseases such as psoriasis, alopecia areata and bullous pemphigoid, evaluating emerging biologic therapies.

  • Psoriasis
  • Alopecia Areata
  • Bullous Pemphigoid

The focus includes disease‑activity scoring and skin‑targeted immune modulation.

Systemic Autoimmune & Inflammatory Disorders

Research extends to systemic conditions like systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome and multiple sclerosis, aiming to modulate pathogenic immune pathways.

  • Systemic Lupus Erythematosus
  • Rheumatoid Arthritis
  • Sjogren's Syndrome
  • Multiple Sclerosis

Efforts target clinical endpoints such as joint erosion, neuro‑inflammation and serologic activity.

Hematologic Malignancies & Oncology

Investigations include B‑cell malignancies and solid tumors, notably chronic lymphocytic leukemia, mantle‑cell lymphoma and melanoma, exploring targeted agents and immune‑based strategies.

  • Chronic Lymphocytic Leukemia
  • Mantle‑Cell Lymphoma
  • Melanoma

Key outcomes involve remission rates and disease‑specific survival metrics.

Respiratory & Pulmonary Diseases

Focus areas comprise severe asthma phenotypes and chronic inflammatory airway disease, with particular attention to moderate‑to‑severe uncontrolled asthma and its exacerbation profile.

  • Moderate‑to‑Severe Uncontrolled Asthma
  • Asthma

Therapeutic evaluation emphasizes airway inflammation control and reduction of exacerbation frequency.

Cardiovascular, Metabolic & Renal Health

Studies address metabolic risk and vascular disease, including obesity, atherosclerotic cardiovascular disease and chronic kidney disease, seeking interventions that affect disease progression.

  • Obesity
  • Atherosclerotic Cardiovascular Disease
  • Chronic Kidney Disease

Endpoints involve cardiovascular event incidence, renal function preservation and metabolic parameter improvement.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.